Tilray Brands (TLRY) Long-Term Investments (2018 - 2026)
Tilray Brands (TLRY) posted Long-Term Investments of $3.3 million for Q1 2026, down 75.58% on a QoQ basis from $13.4 million in Q4 2025.
Tilray Brands (TLRY) Long-Term Investments (2018 - 2026) Analysis & Trends
Tilray Brands' Long-Term Investments history runs 9 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $3.3 million (changed N/A YoY) and the FY2025 annual result came in at $8.2 million, up 3.83% from the prior year.
- Long-Term Investments was $3.3 million for Q1 2026 at Tilray Brands, down from $13.4 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $133.2 million in Q1 2022 and bottomed at $3.3 million in Q1 2026.
- A 5-year average of $15.4 million and a median of $7.9 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 97.44% — and 2025, when it soared 80.6%.
- Tilray Brands' Long-Term Investments stood at $8.2 million in 2022, then declined by 2.16% to $8.0 million in 2023, then declined by 7.69% to $7.4 million in 2024, then surged by 80.6% to $13.4 million in 2025, then plunged by 75.58% to $3.3 million in 2026.
- Business Quant data shows TLRY's Long-Term Investments at $3.3 million in Q1 2026, $13.4 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.27 Mn |
| Nov 30, 2025 | 13.39 Mn |
| Aug 31, 2025 | 10.17 Mn |
| May 31, 2025 | 8.16 Mn |
| Nov 30, 2024 | 7.42 Mn |
| Aug 31, 2024 | 7.85 Mn |
| May 31, 2024 | 7.86 Mn |
| Feb 29, 2024 | 8.06 Mn |
| Nov 30, 2023 | 8.03 Mn |
| Aug 31, 2023 | 7.56 Mn |
| May 31, 2023 | 4.58 Mn |
| Feb 28, 2023 | 4.64 Mn |
| Nov 30, 2022 | 8.21 Mn |
| Aug 31, 2022 | 4.76 Mn |
| May 31, 2022 | 10.05 Mn |
| Feb 28, 2022 | 133.16 Mn |
| Nov 30, 2021 | 168.24 Mn |
| Aug 31, 2021 | 186.41 Mn |
| May 31, 2021 | 17.69 Mn |
| May 31, 2020 | 19.60 Mn |